Nantes, September 27, 2022 – 6:00 p.m. CEST – Pherecydes Pharma (FR0011651694 – ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections, announces today that its management team has participated or participate in the following scientific and investor events:
• World Anti-Microbial Resistance Congress
September 7-8, 2022 (Washington)
• 17th National Congress of the French Society of Microbiology
From October 3 to 5, 2022 (Montpellier)
• Phages in Paris
From October 11 to 13, 2022 (Paris)
• Phages Future US 2022/ 7th Annual Microbiome Connect: US 2022
November 16-17, 2022 (Boston)
• Biotech & Health Seminar at Portzamparc BNP Paribas
October 4, 2022 (virtual event)
• HealthTech Innovation Days
October 13 and 14, 2022 (Paris)
• BIO-Europe 2022
October 24-26, 2022 (Leipzig)
To receive all of Pherecydes Pharma’s financial information in real time, send a request by email to [email protected]. Your registration will be immediate.